Revance Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hello, everyone. I'm Nater Surabhi from the JPMorgan Healthcare Investment Banking team. On behalf of JPMorgan, it's my pleasure to introduce Mark Foley, Chief Executive Officer of Revance. As a reminder, we will try to reserve a few minutes at the end for Q&A. So if you have any questions, please submit them online using the ask a question feature at the bottom of the screen.
I will now turn it over to Mark. Thank you.
Great. Thanks, Nater, and thanks to the entire JPMorgan Healthcare team for having us as part of the conference. Look forward to giving you a company update here today.
You'll be able to click through the slides on your end, so I'll do my best to reference the different slides so that you can follow along. So moving from Slide 1 to Slide 2, this is our forward-looking statement as there will be different comments that we've been making about potential forward-looking results, which may end up differing.
Moving on to Slide 3,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |